NCT00258557 – Phase III Randomized, Controlled, Open-label Trial to Investigate the Antiviral Activity, Tolerability and Safety of TMC114/r in Treatment- Naive HIV-1 Infected Patients Posted on July 27, 2016 by tsuperadmin -
NCT00645307 – A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study With an Open-Label Extension Evaluating Extended Release OROS® Paliperidone in the Prevention of Recurrence in Subjects With Schizophrenia – Open Label Phase Posted on July 18, 2016 by tsuperadmin -
NCT00973479 – A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFalpha Monoclonal Antibody, Administered Intravenously, in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy Posted on June 23, 2016 by tsuperadmin -
NCT00269854 – A Placebo-Controlled, Dose-Ranging Study Followed by a Placebo-Controlled, Repeated-Dose Extension of Anti-TNF Chimeric Monoclonal Antibody (cA2) in the Treatment of Patients With Active Crohn’s Disease Posted on June 15, 2016 by tsuperadmin -
NCT01190839 – Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn’s Disease Patients Undergoing Surgical Resection Who Are at Increased Risk of Recurrence Posted on June 15, 2016 by tsuperadmin -
NCT00236431 – A Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment (MCI) Clinically at Risk for Development of Clinically Probable Alzheimer’s Disease Posted on June 8, 2016 by tsuperadmin -
NCT00236574 – A Randomized Double Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment (MCI) Clinically at Risk for Development of Clinically Probable Alzheimer’s Disease Posted on June 8, 2016 by tsuperadmin -
NCT00253214 – Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer’s Disease: Safety and Efficacy of a Controlled-Release Formulation Posted on June 8, 2016 by tsuperadmin -
NCT00253188 – Efficacy, Tolerability and Safety of Galantamine in the Treatment of Alzheimer’s Disease Posted on June 8, 2016 by tsuperadmin -
NCT00261573 – The Safety and Efficacy of Galantamine in the Treatment of Vascular and Mixed Dementia Posted on June 8, 2016 by tsuperadmin -
The YODA Project